HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

BACKGROUND: European guidelines for cervical cancer screening now recommend the use of clinically validated assays for high-risk HPV-DNA sequences as primary test in women older than 30 years, performed in centralized laboratories, and run on systems providing automated solutions for all steps. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Frayle, Helena, Gori, Silvia, Rizzi, Martina, Graziani, Bianca Nives, Vian, Elisa, Giorgi Rossi, Paolo, Del Mistro, Annarosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434866/
https://www.ncbi.nlm.nih.gov/pubmed/30909894
http://dx.doi.org/10.1186/s12905-019-0743-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434866/
https://www.ncbi.nlm.nih.gov/pubmed/30909894
http://dx.doi.org/10.1186/s12905-019-0743-0

Ejemplares similares